Connect with us

Technology

Notice of Annual General Meeting of Implantica AG

Published

on

VADUZ, Liechtenstein, April 25, 2025 /PRNewswire/ — The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Thursday, May 15, 2025, at 14:00 at Hotel Kommod, Industriering 14, 9491 Ruggell, Liechtenstein.

Right to participate and notice

Anyone wishing to attend the annual general meeting must:

be entered as depository receipt holder in the Swedish Depository Receipt (“SDR”) register kept by the Swedish central securities depository Euroclear Sweden on Wednesday, April 30, 2025, andnotify the company of their intention to attend no later than May 7, 2025, by email to investorrelations@implantica.com or by post to Implantica AG, Annual General Meeting, Aeulestrasse 45, 9490 Vaduz, Liechtenstein

When giving notification to attend, please specify the SDR holder’s name, personal identity or company registration number, address, telephone number and the number of any representative (no more than two).

in lieu of physical participation, votes may be cast by the SDR holder no later than Wednesday, May 7, 2025, in accordance with the instructions on the Postal Voting Form, see appendix 1, so that the voting form is received by Pareto Securities AB (the “Custodian”) no later than that day. The Custodian will forward the votes for representation to the local independent proxy, Mr. Philipp Wanger, Attorney-at-law.

If SDR holders are represented by a proxy, a written and dated power of attorney signed by the SDR holder must be issued to the proxy. The power of attorney must not be older than one year, unless a longer validity term (maximum five years) has been stipulated. Anyone representing a legal entity must present a copy of the registration certificate or other document demonstrating the signatory’s authority to sign for the legal entity. In order to facilitate registration at the annual general meeting, the power of attorney as well as the registration certificate and other authorization documents should be received by the company at the above address by May 7, 2025, at the latest.

Holders of depository receipts who hold their receipts through nominees (Sw. förvaltare), such as a bank, must request a temporary registration of the voting rights in their own name in the share register kept by Euroclear Sweden (so called voting right registration) in order to be able to participate at the annual general meeting. Holders of depository receipts who want to obtain such registration must contact the nominee regarding this in advance of April 30, 2025.

Proposed agenda

Opening of the meeting and appointment of the Chair of the meetingPreparation and approval of the voting listApproval of the agendaAppointment of one or two persons to approve the minutesDetermination of whether the meeting has been duly convenedAddress by the CEO and CFOPresentation of the annual report, the statutory annual financial statements, the consolidated financial statements and auditor’s reportsResolution and adoption of the statutory financial statements and the consolidated financial statements of Implantica AG, acknowledging the reports of the auditorsResolution on the net result in accordance with the adopted balance sheetResolution on discharge of the Board of Directors, Executive Management and the AuditorsResolution on approval of remuneration of the Board of Directors and Executive ManagementElection of the Board of Directors and the Chairman and Vice-Chairman of the Board of Directors Election of the Chairman of the Board of DirectorsElection of the Vice-Chairman of the Board of DirectorsElection of the members of the Board of DirectorsElection of the Chairman and the member of the Nomination and Remuneration CommitteeElection of the independent proxyElection of the auditorsResolution on amendment of Article 4a para. 1 of the Articles of AssociationResolution on amendment of Article 4 para. 5 of the Articles of AssociationClosing of the meeting

Resolution proposals and Elections

The following agenda items are scheduled for the Annual General Meeting (“AGM”):

8. Resolution and adoption of the statutory financial statements and the consolidated financial statements of Implantica AG

Proposal of the Board of Directors:

Approval of the annual report 2024 consisting of the statutory financial statements and the consolidated financial statements of Implantica AG, acknowledging the reports of the auditors.

9. Resolution on the net result in accordance with the adopted balance sheet

Proposal of the Board of Directors:
Carry forward of the net loss for the financial year 2024 in accordance with the adopted balance sheet and to no payment of dividend.

10. Resolution on discharge of the Board of Directors, Executive Management and the Auditors

Proposal of the Board of Directors:

Granting of discharge to the members of the Board of Directors for financial year 2024.Granting of discharge to the members of the Executive Management for financial year 2024.Granting of discharge to the Auditor for financial year 2024.

11. Resolution on approval of remuneration of the Board of Directors and Executive Management

Proposal of the Board of Directors:

Approve the total remuneration of the Board of Directors of TEUR 106 for financial year 2024. The total remuneration includes fixed compensation, pension contributions and a long-term share-based incentive plan.Approve the total remuneration of the Executive Management of TEUR 821 for financial year 2024. The total remuneration includes fixed compensation, pension contributions and a long-term share-based incentive plan. Executive Management is made up of the Chief Executive Officer, the Chief Financial Officer, the Chief Strategy Officer and the Chief Corporate Affairs Officer.

12. Election of the Board of Directors and the Chairman and Vice-Chairman of the Board of Directors

The Board of Directors of the company currently consists of four ordinary members. It is proposed to re-elect all current board members for the period until the end of the next annual general meeting including the re-election of Liselott Kilaas as Chairman and Johan Bojs as Vice-Chairman.

Proposal of the Board of Directors:

Re-election of Liselott Kilaas as member and Chairman of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Johan Bojs as member and Vice-Chairman of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Tomas Puusepp as member of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.Re-election of Stephan Siegenthaler as member of the Board of Directors for a term of office until completion of the next Annual General Meeting of shareholders.

13. Election of members and Chairman of the Nomination and Remuneration Committee

Proposal of the Board of Directors: 

Re-election of Johan Bojs as Chairman of the Nomination and Remuneration Committee for a term of office until completion of the next Annual General Meeting of shareholders.Election of Tomas Puusepp as member of the Nomination and Remuneration Committee for a term of office until completion of the next Annual General Meeting of shareholders.

14. Election of the independent proxy

Proposal of the Board of Directors: 

Re-election of Philipp Wanger, Attorney-at-law, Neugasse 17, 9490 Vaduz, Liechtenstein as independent proxy until the next annual general meeting of shareholders.

15. Election of the auditors

Proposal of the Board of Directors:

Re-election of KPMG (Liechtenstein) AG, Aeulestrasse 2, 9490 Vaduz, Liechtenstein as auditor for the financial year 2025.

16. Resolution on amendment of Article 4a para. 1 of the Articles of Association

Resolve on an authorization for the board of directors to, with or without deviation from the shareholders’ preferential rights, resolve on new share issues. The objective of the authorization is to provide the board of directors with flexibility in its work to ensure that the company can procure capital for the financing of the operations in an appropriate manner, to enable business or company acquisitions and to enable a broadening of the company’s shareholder base.

Proposal of the Board of Directors:
Art. 4a para. 1: The Board of Directors is authorized to increase the share capital, at any time until May 14, 2030, by a maximum amount of CHF 69’461’536 by issuing a maximum of 34’730’768 fully paid up registered ordinary shares (Class A) with a par value of CHF 2 each. An increase of the share capital in partial amounts shall be permissible.

Art. 4a Abschnitt 1: Der Verwaltungsrat ist ermächtigt, jederzeit bis zum 14. Mai 2030 das Aktienkapital im Maximalbetrag von CHF 69’461’536 durch Ausgabe von höchstens 34’730’768 voll zu liberierenden auf den Namen lautende Aktien (Class A) mit einem Nennwert von je CHF 2 zu erhöhen. Erhöhungen in Teilbeträgen sind gestattet.

17. Resolution on amendment of Article 4 para. 5 of the Articles of Association

Resolve on an authorization for the board of directors to, with or without deviation from the shareholders’ preferential rights, resolve on new share issues for the exercise of contingent capital comprising conversion rights or options in relation with convertible debt instruments. The objective of the authorization is to provide the board of directors with flexibility in its work to ensure that the company can procure capital for the financing of the operations in an appropriate manner, to enable business or company acquisitions and to enable a broadening of the company’s shareholder base. Furthermore, to resolve on adding the sentence, “An increase of the share capital in partial amounts shall be permissible,” to this Article 4 para. 5.

Proposal of the Board of Directors:
Art. 4 para. 5: The share capital may be increased by a maximum of CHF 69’461’536 through the issuance of a maximum of 34’730’768 fully paid up registered ordinary shares (Class A) with a par value of CHF 2 each by means of the exercise of conversion rights or options in relation with convertible debt instruments, loans and similar forms of financing of the Company or of a subsidiary company. The conditions for the granting of the option rights and conversion rights shall be determined by the Board of Directors. The Board of Directors is authorized to restrict or exclude shareholders’ advance subscription rights if the convertible debt instruments, loans and similar forms of financing are used, (i) in connection with the financing and refinancing of the business of the Company or its subsidiaries or (ii) in connection with the financing and refinancing of the takeover of companies, parts of companies, interests or co-operations or strategic partnerships. To the extent shareholders’ advance subscription rights are excluded, the exercise period for conversion and option rights granted shall not exceed 5 years and the conversion or exercise price for the new shares to be issued shall at least correspond to the market conditions at the time of the issue of the relevant debt or loan instrument. An increase of the share capital in partial amounts shall be permissible.

Art. 4 Abschnitt 5: Das Aktienkapital kann sich durch Ausgabe von maximal 34’730’768 voll zu liberierenden Namenaktien (Class A) im Nennwert von je CHF 2 um maximal CHF 69’461’536 erhöhen, infolge der Ausübung von Wandel- oder Optionsrechte, welche in Zusammenhang mit Wandelschuldinstrumenten, Wandeldarlehen und ähnlichen Finanzierungsformen der Gesellschaft oder einer ihrer Tochtergesellschaften eingeräumt worden sind. Die Ausgabebedingungen für die Options- und Wandelrechte werden durch den Verwaltungsrat festgelegt. Der Verwaltungsrat ist ermächtigt, das Vorwegzeichnungsrecht der Aktionäre aufzuheben oder einzuschränken, sofern die Wandelschuldinstrumente, Wandeldarlehen und ähnliche Finanzierungsformen (i) im Zusammenhang mit der Finanzierung und Refinanzierung der Gesellschaft oder ihrer Tochtergesellschaften, oder (ii) im Zusammenhang mit der Finanzierung und Refinanzierung der Übernahme von Unternehmen, Unternehmensteilen, Beteiligungen oder Kooperationen und strategischen Partnerschaften verwendet werden. Soweit das Vorwegzeichnungsrecht ausgeschlossen ist, ist die Ausübungsfrist auf höchstens fünf Jahre und der Ausgabepreis für die neuen Aktien mindestens zu den Marktbedingungen zum Zeitpunkt der Ausgabe des Schuldinstruments bzw. Darlehens anzusetzen. Erhöhungen in Teilbeträgen sind gestattet.

Number of shares and votes in the company

Implantica AG has two classes of shares, class A and class B. The class A shares are listed on the Nasdaq First North Premier Growth Market, through Swedish Depository Receipts (“SDRs”). One SDR represents one class A share in Implantica AG. Each class A and class B share provide entitlement to one vote. The total number of class A shares in the company amounts to 58,211,537 shares with a nominal value of CHF 2.00 each (class A) and 1,125,000,000 class B shares with a nominal value of CHF 0.02 each (class B), therefore, the total number of votes in the company amounts to 1,183,211,537 votes. At the date of this notice, there are 14,321 SDRs representing treasury class A shares, which cannot be represented at the annual general meeting.

Information at the meeting

The board of directors and the CEO shall, if any SDR holder so requests and the board of directors believes that it can be done without material harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances which may affect the assessment of the company’s or subsidiaries’ financial position and circumstances that may affect the company’s relation to other companies within the group. SDR holders who want to submit questions in advance may do so in writing by way of e-mail at investorrelations@implantica.com

Documents

Complete proposals and statements, including the auditor’s statement, as well as accounting documents and audit report for 2024, will be available at the company’s offices on Aeulestrasse 45, 9490 Vaduz, Liechtenstein and on the company’s website, www.implantica.com, no later than three weeks before the general meeting.

Minutes

The minutes of the annual general meeting will be available for review from the evening of June 13, 2025, at the latest at the company’s headquarters, Aeulestrasse 45, 9490 Vaduz, Liechtenstein and on the company’s website www.implantica.com.

Processing of personal data

For information on how your personal data is processed, see https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.

Implantica AG
The Board of Directors
April 25, 2025

For further information, please contact:
Nicole Pehrsson, Chief Corporate Affairs Officer
Telephone (CH): +41 (0)79 335 09 49
nicole.pehrsson@implantica.com

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company’s Certified Adviser is FNCA Sweden AB, info@fnca.se

The information was sent for publication, through the agency of the contact person set out above, on April 25, 2025, at 10:15 a.m. CEST.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica’s lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

Newsroom
https://www.implantica.com/media/media-kit

Media Contact:
Implantica AG
Juanita Eberhart, VP Marketing & Advocacy
M: +1 925-381-4581
juanita.eberhart@implantica.com 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/notice-of-annual-general-meeting-of-implantica-ag,c4140327

The following files are available for download:

https://mb.cision.com/Main/19732/4140327/3409554.pdf

Notice of 2025 Annual General Meeting of Implantica AG

https://mb.cision.com/Public/19732/4140327/90ea26b536ff7c5d.pdf

Form for advanced postal voting

View original content:https://www.prnewswire.co.uk/news-releases/notice-of-annual-general-meeting-of-implantica-ag-302438228.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

SiriusXM Declares Quarterly Cash Dividend

Published

on

By

NEW YORK, July 22, 2026 /PRNewswire/ — SiriusXM (NASDAQ: SIRI) today announced that its Board of Directors declared a quarterly cash dividend of $0.27 per share of common stock. This regular quarterly dividend is payable in cash on August 26, 2026, to stockholders of record at the close of business on August 10, 2026.

About Sirius XM Holdings Inc.
SiriusXM is the leading audio entertainment company in North America with a portfolio of audio businesses including its flagship subscription entertainment service SiriusXM; the ad-supported and premium music streaming services of Pandora; an expansive podcast network; and a suite of business and advertising solutions. Together, SiriusXM reaches a combined monthly audience of approximately 255 million listeners. SiriusXM offers a broad range of content for listeners everywhere they tune in with a diverse mix of live, on-demand, and curated programming across music, talk, news, and sports. For more about SiriusXM, please go to: www.siriusxm.com.

Source: SiriusXM

Investor contacts:
Jennifer DiGrazia
investor.relations@siriusxm.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/siriusxm-declares-quarterly-cash-dividend-302832548.html

SOURCE Sirius XM Holdings Inc.

Continue Reading

Technology

Shutterstock Announces Capital Allocation Update

Published

on

By

NEW YORK, July 22, 2026 /PRNewswire/ — Shutterstock, Inc. (NYSE: SSTK) (the “Company”), a family of brands delivering scalable creative and GenAI solutions to help customers fuel great work, today announced that at a meeting held on July 20, 2026 its Board of Directors (the “Board”) resolved to suspend the Company’s future quarterly cash dividend.

The Board’s determination reflects its ongoing review of the Company’s capital-allocation priorities and its focus on deploying capital to support long-term value creation for shareholders, including reducing debt, minimizing related interest expense and strengthening financial flexibility.

The Board will continue to evaluate the Company’s capital allocation priorities as part of its regular governance process. Any future declaration and payment of dividends, and the amount thereof, will remain subject to the discretion of the Board and will depend upon the Company’s results of operations, financial condition, capital requirements, contractual restrictions, applicable law, and such other factors as the Board deems relevant.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements may discuss intentions and expectations as to future plans, trends, events, results of operations or financial condition, or otherwise. Forward-looking statements speak only as of the date they are made and should not be relied upon as predictions of future events, as there can be no assurance that the events or circumstances reflected in these statements will occur. Forward-looking statements can often, but not always, be identified by the use of forward-looking terminology including “believes,” “could,” “expects,” “intends,” “may,” “might,” “ongoing,” “plans,” “seeks,” “should,” “will,”  or the negative of these words and phrases, other variations of these words and phrases or comparable terminology, but not all forward-looking statements include such identifying words. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those indicated or anticipated by such forward-looking statements. The forward-looking statements in this press release relate to, among other things, the Company’s capital allocation strategy, the suspension of the Company’s quarterly cash dividend, the Company’s plans with respect to debt reduction, interest expense management and financial flexibility, and any future declaration and payment of dividends. For a discussion of factors that could cause actual results to differ materially from those contemplated by forward-looking statements, see the sections captioned “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, the Company’s Quarterly Reports on Form 10-Q, and the Company’s other filings with the Securities and Exchange Commission. While those factors are considered representative, no list of risk factors should be considered a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. The Company assumes no obligation to update forward-looking statements, and the Company disclaims any such obligation, except as may be required by law.

About Shutterstock
Shutterstock is in the business of turning ideas into impact. Powered by a global network of millions of creators and our cutting-edge technology, we provide businesses, creatives, and brand leaders with the essential, universal ingredients to make their work more effective. Shutterstock offers access to one of the world’s largest and most diverse collections of high-quality licensable assets, specialized training datasets, evaluation tools, and end-to-end strategic partnerships for the full model training lifecycle, as well as advertising and distribution solutions, exclusive editorial content, and full-service studio production—delivering unparalleled resources to fuel great work.

Discover our impact at www.shutterstock.com and connect with us on LinkedIn, Instagram, X, Facebook and YouTube.

View original content to download multimedia:https://www.prnewswire.com/news-releases/shutterstock-announces-capital-allocation-update-302832484.html

SOURCE Shutterstock, Inc.

Continue Reading

Technology

ICI Welcomes Bipartisan Sponsors of Bill to Stop States from Seizing Long-Term Investors’ Savings

Published

on

By

WASHINGTON, July 22, 2026 /PRNewswire/ — The Investment Company Institute released the following Viewpoints blog. To learn more about why this issue matters and how the SAFER Act would help protect American investors, watch our video on LinkedIn.

Millions of American investors have adopted the advice given by financial advisors to invest for the long term and then leave those savings alone. In some states, however, following this guidance can get your account seized. That was the warning sounded at an event featuring the sponsors of the bipartisan SAFER Act, Representatives Sam Liccardo (D-CA) and Mike Lawler (R-NY), who joined ICI leaders to make the case for a federal solution to the problem of state unclaimed property laws that can treat buy-and-hold investors as though they have disappeared. 

ICI President and CEO Eric Pan opened the event by outlining the nature of this growing threat. More than 128 million Americans invest in regulated funds, many with the intention of holding them for years, following the advice of many financial educators to “stay in the market, invest for the long term.” They put their money away and go about their lives, confident that the savings will be there when they need it. But under some states’ laws, an account that shows no activity can be declared abandoned and taken into state custody through a process called escheatment.

Pan walked through what seizure means in practice. When a state escheats an investment account, it typically liquidates the holdings — so even an investor who eventually recovers the money gets back only what the account was worth at seizure, with no credit for years of market gains. For retirement accounts, the forced liquidation can also trigger unforeseen tax consequences. And recovering the money at all can take years of paperwork and persistence. Meanwhile, some states are moving in the wrong direction, loosening their rules to make it easier to capture assets. 

“This is where the leadership of Congressmen Lawler and Liccardo is so important,” Pan said. “They’ve introduced the SAFER Act, a federal solution to a problem that exists across the United States. This patchwork of different legal standards, and the fact that the legal standards change constantly, creates a lot of confusion and creates this risk and harm that we’re so worried about.” 

In a panel discussion, the two lawmakers described the issue as an obvious place for Democrats and Republicans to find common ground, given Americans’ widespread use of investment accounts for saving.

“We are, for the most part, a group of Americans who sit on our investments, which is more or less the right strategy,” Liccardo said, noting that this is exactly the approach that inactivity standards put at risk. 

Liccardo pointed to the widely reported case of Walter Schramm, an investor who bought Amazon shares in the late 1990s and then did what many long-term investors do: leave the account be. Delaware deemed the account abandoned and liquidated the shares in 2008, when they worth about $8,000. By the time Schramm discovered what happened years later, the position would have been worth roughly $100,000.

The financial incentives driving state behavior are a concern, Liccardo noted. Unclaimed property has become one of Delaware’s largest sources of revenue, bringing in more than half a billion dollars a year — a powerful reason for states to loosen their standards rather than tighten them. 

Lawler contrasted legitimate unclaimed property programs and what some states are doing now. “It’s one thing to get an asset because it’s truly abandoned,” he said. “It’s another to basically target a group of investors who have a long-term strategy of just not touching the asset and being passive.”

The right standard, Lawler argued, is the obvious one: before seizing investment assets, a state should have to prove the owner is actually deceased. He posited that most Americans would be shocked to learn how little protection they have. “You think you have ownership of this asset, but the state, under current law, can just take it.”

The SAFER Act would establish federal guardrails ensuring that inactivity alone cannot be the basis for escheatment and that states confirm the death of an owner and that no estate or beneficiary has claimed the assets before escheating investment accounts. It would also require states to leave unclaimed investments in place, rather than liquidating them, until they can prove abandonment.

Both lawmakers said the path to fixing the problem is through public awareness of the threat some state laws pose to Americans financial security. “Ultimately the American people will rise up,” Liccardo said. “It may take a little while. We just have to get the information to them.”

Contact: media@ici.org 

View original content to download multimedia:https://www.prnewswire.com/news-releases/ici-welcomes-bipartisan-sponsors-of-bill-to-stop-states-from-seizing-long-term-investors-savings-302832606.html

SOURCE Investment Company Institute

Continue Reading

Trending